Reuters
reuters.com
did:plc:jbvnehrrdqoulco4rf5gxg5r
Some drugmakers quietly concerned about legal risk with speedy FDA review program reut.rs/45e4Ktk https://reut.rs/45e4Ktk
2026-01-16T15:05:10.038Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.